Oral cabotegravir and rilpivirine still effective at 312 weeks
Adherence to ART: is the gold standard still needed for viral suppression?
Massive decline in suicides of HIV-positive people since the introduction of combination therapy, but rate remains high
HIV outcomes for transgender women improved by addressing social and structural issues
Opioid overdose deaths are rising among people with HIV in the United States
Multiple benefits to scaling up universal test and treat in Africa
DAA treatment reduces the risk of death and liver cancer in people with hepatitis C
Glimmers of hope: moving towards better HIV and TB treatment in eastern Europe
